Cubist Systematic Strategies’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-264,642
Closed -$6.87M 3143
2024
Q3
$6.87M Buy
+264,642
New +$6.58M 0.04% 652
2024
Q2
Sell
-253,289
Closed -$6.01M 3290
2024
Q1
$6.01M Sell
253,289
-280,290
-53% -$6.23M 0.03% 852
2023
Q4
$12.8M Sell
533,579
-487,620
-48% -$10.6M 0.08% 324
2023
Q3
$22.3M Buy
1,021,199
+553,697
+118% +$11.6M 0.16% 104
2023
Q2
$8.93M Sell
467,502
-75,936
-14% -$1.46M 0.06% 491
2023
Q1
$10.5M Buy
543,438
+487,786
+876% +$8.5M 0.06% 431
2022
Q4
$893K Sell
55,652
-213,013
-79% -$3.47M 0.01% 2562
2022
Q3
$4.21M Sell
268,665
-102,157
-28% -$1.97M 0.02% 1241
2022
Q2
$7.72M Buy
370,822
+42,029
+13% +$866K 0.05% 632
2022
Q1
$7.45M Buy
328,793
+181,602
+123% +$3.55M 0.06% 456
2021
Q4
$2.69M Sell
147,191
-76,844
-34% -$1.47M 0.03% 1116
2021
Q3
$4.74M Buy
224,035
+15,048
+7% +$279K 0.06% 489
2021
Q2
$3.81M Buy
208,987
+36,815
+21% +$859K 0.04% 702
2021
Q1
$3.89M Buy
172,172
+82,296
+92% +$1.86M 0.05% 579
2020
Q4
$1.8M Sell
89,876
-111,676
-55% -$2.34M 0.02% 1010
2020
Q3
$4.93M Sell
201,552
-188,191
-48% -$4.39M 0.07% 418
2020
Q2
$9.25M Buy
389,743
+174,720
+81% +$4.05M 0.16% 115
2020
Q1
$3.7M Buy
215,023
+200,262
+1,357% +$3.66M 0.1% 251
2019
Q4
$260K Buy
14,761
+11,461
+347% +$194K ﹤0.01% 1922
2019
Q3
$58K Sell
3,300
-28,488
-90% -$577K ﹤0.01% 2021
2019
Q2
$679K Sell
31,788
-76,393
-71% -$1.6M 0.01% 1285
2019
Q1
$2.58M Buy
108,181
+20,704
+24% +$472K 0.08% 345
2018
Q4
$1.72M Buy
87,477
+70,895
+428% +$1.26M 0.08% 339
2018
Q3
$294K Sell
16,582
-1,175
-7% -$22.9K 0.02% 1171
2018
Q2
$382K Sell
17,757
-9,104
-34% -$188K 0.02% 933
2018
Q1
$595K Sell
26,861
-22,093
-45% -$611K 0.03% 705
2017
Q4
$1.49M Sell
48,954
-8,960
-15% -$238K 0.08% 328
2017
Q3
$1.4M Buy
57,914
+20,266
+54% +$539K 0.08% 286
2017
Q2
$927K Buy
37,648
+14,224
+61% +$301K 0.06% 458
2017
Q1
$508K Sell
23,424
-81,034
-78% -$1.65M 0.04% 630
2016
Q4
$1.56M Buy
104,458
+47,894
+85% +$691K 0.12% 220
2016
Q3
$723K Buy
56,564
+30,609
+118% +$331K 0.05% 549
2016
Q2
$203K Buy
25,955
+7,285
+39% +$42K 0.01% 1326
2016
Q1
$75K Sell
18,670
-97,941
-84% -$415K ﹤0.01% 1437
2015
Q4
$658K Sell
116,611
-76,568
-40% -$428K 0.04% 683
2015
Q3
$1.08M Buy
193,179
+180,579
+1,433% +$983K 0.05% 538
2015
Q2
$47K Sell
12,600
-5,380
-30% -$17.5K ﹤0.01% 1710
2015
Q1
$46K Buy
17,980
+5,380
+43% +$12.5K ﹤0.01% 1767
2014
Q4
$18K Hold
12,600
﹤0.01% 1822
2014
Q3
$19K Sell
12,600
-4,700
-27% -$15.1K ﹤0.01% 1682
2014
Q2
$59K Buy
+17,300
New +$59.7K ﹤0.01% 1397

Other funds holding EXEL

Cubist Systematic Strategies's EXEL Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Exelixis (EXEL) in Q4 2024, closing a stake of 264,642 shares — an estimated $6.87M sold.

Cubist Systematic Strategies first reported a position in EXEL in Q2 2014 and held it in 41 quarters. The position peaked at $22.3M in Q3 2023. 518 funds tracked by Wall St. Rank hold EXEL as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Exelixis position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 264,642 Exelixis shares in Q4 2024, an estimated $6.87M.
  • Cubist Systematic Strategies first reported a position in Exelixis in Q2 2014 and held it in 41 quarters.
  • Cubist Systematic Strategies's Exelixis position peaked at $22.3M in Q3 2023.
  • 518 funds tracked by Wall St. Rank held Exelixis as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.